How do I buy shares of 1724525 (ADN.L)?

Shares of ADN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

What other stocks do shareholders of 1724525 (ADN.L) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that 1724525 (ADN.L) investors own include Babcock International Group (BAB) , Bayerische Motoren Werke Aktiengesellschaft (BMW) , Centrica (CNA) , Lloyds Banking Group (LLOY) , Barclays (BARC) , The Berkeley Group (BKG) and Oshkosh (OSK) .

LON:ADN

1724525 (ADN.L) (ADN) Share Price, News & Analysis

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: 3.09 million shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get 1724525 (ADN.L) alerts:

Ad Crypto Swap Profits

625,000% Gain

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

About 1724525 (ADN.L) Stock (LON:ADN)

Aberdeen Asset Management PLC is a United Kingdom-based asset manager. The Company operates through asset management for reporting and control purposes. The Company is managed as a single asset management business, with multiple investment strategies of equities, fixed income and property, complemented by a solutions business, which provides multi asset, alternatives and quantitative investment capabilities. These strategies are managed across a range of products, distribution channels and geographic regions. The Company holds investments in seed capital investments, investments in certain Aberdeen-managed funds to hedge deferred fund awards and other investments. The Company operates in approximately 20 countries. Its operations span across Asia Pacific, Australia, the United Kingdom, the United States, the Middle East and Europe, among others.

Ad Crypto Swap Profits

625,000% Gain

>> Dive into the Workshop Here

ADN Stock News Headlines

A woman walks in front of the Bank of England, at the financial district in London, on March 23, 20…

July 17, 2024 | marketbeat.com

UK inflation stays at 2% target in June, leaving possible rate cut on a 'knife edge'

Inflation in the U.K. held steady at the Bank of England’s target rate of 2% in June

July 1, 2023 | health.usnews.com

Dr. Russell G. Hirano

July 27, 2024 | Crypto Swap Profits (Ad)

625,000% Gain

November 15, 2022 | finance.yahoo.com

Advent Technologies Holdings, Inc. (ADN)

See More Headlines

Receive ADN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 1724525 (ADN.L) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Manufacturing
Industry: Optical Instrument & Lens Manufacturing
Sub-Industry: Electrical Equipment
Current Symbol: LON:ADN
CUSIP: N/A
CIK: N/A
Web: www.aberdeen-asset.com
Phone: +44-1224-631999
Fax: N/A
Employees: 200
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Martin James Gilbert LL.D.
M.D., Chief Executive, Executive Director
Andrew A. Laing
Deputy Chief Executive, Executive Director
Bever Hendry
Co-Head of Americas and Chief Financial Officer
W. J. Rattray
Finance Director, Executive Director
Martin Jennings
Chief Executive Officer Parmenion and Head of Aberdeen Digital
Avril McLean
Chief Technology Officer
Gordon H. Brough
General Counsel
Hugh Young
Managing Director of Aberdeen Asset Management Asia, Executive Director
Roderick MacLeod MacRae
Group Head - Risk, Executive Director
Kerry Christie
Global Head - Human Resources

Key Competitors

View All Competitors

ADN Stock Analysis - Frequently Asked Questions

How do I buy shares of 1724525 (ADN.L)?: Shares of ADN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What other stocks do shareholders of 1724525 (ADN.L) own?: Based on aggregate information from My MarketBeat watchlists, some other companies that 1724525 (ADN.L) investors own include Babcock International Group (BAB), Bayerische Motoren Werke Aktiengesellschaft (BMW), Centrica (CNA), Lloyds Banking Group (LLOY), Barclays (BARC), The Berkeley Group (BKG) and Oshkosh (OSK).